| Literature DB >> 27867403 |
Bárbara O Henriques1, Olívia Corrêa1, Elaine Patrícia C Azevedo1, Rodrigo M Pádua1, Vívian Louise S de Oliveira2, Thiago Henrique C Oliveira2, Daiane Boff2, Ana Carolina F Dias3, Danielle G de Souza3, Flávio A Amaral2, Mauro M Teixeira2, Rachel O Castilho1, Fernão C Braga1.
Abstract
Stryphnodendron species, popularly named "barbatimão," are traditionally used in Brazil as anti-inflammatory agents. This study aimed to investigate the effect of barbatimão and 11 other species on the production of tumor necrosis factor-alpha (TNF-α) in lipopolysaccharide- (LPS-) stimulated THP-1 cells, as well as their anti-arthritis activity. The extracts of Stryphnodendron adstringens, Stryphnodendron obovatum, Campomanesia lineatifolia, and Terminalia glabrescens promoted a concentration-dependent inhibition of TNF-α. Mice injected with LPS in the knee joint were treated per os with fractions from the selected extracts. Both the organic (SAO) and the aqueous (SAA) fractions of S. adstringens promoted a dose-dependent reduction of leukocyte migration and neutrophil accumulation into the joint, but none of them reduced CXCL1 concentration in the periarticular tissue. In contrast, treatment with C. lineatifolia and T. glabrescens fractions did not ameliorate the inflammatory parameters. Analyses of SAO by Ultra Performance Liquid Chromatography (UPLC) coupled to electrospray ionization mass spectrometry (ESI-MS) led to the identification of gallic acid along with 11 prodelphinidins, characterized as monomers and dimers of the B-type. Our findings contribute to some extent to corroborating the traditional use of S. adstringens as an anti-inflammatory agent. This activity is probably related to a decrease of leukocyte migration into the inflammatory site. Polyphenols like gallic acid and prodelphinidins, identified in the active fraction, may contribute to the observed activity.Entities:
Year: 2016 PMID: 27867403 PMCID: PMC5102725 DOI: 10.1155/2016/9872598
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Brazilian plants selected for study with their botanical and popular names, data of collection, voucher numbers, and ethnopharmacological uses.
| Botanical name | Family | Location | Voucher number | Ethnopharmacological uses | References |
|---|---|---|---|---|---|
|
| Fabaceae | Belo Horizonte, MG | BHCB 166999 | Diarrhea, gout, diabetes, bronchitis, hyperthermia, inflammation of the uterus, and rheumatism | [ |
|
| Myrtaceae |
| BHCB 150.606 | Dysentery, stomach and liver problems, diarrhea, problems of the urinary tract, and leucorrhea | [ |
|
| Boraginaceae |
| BHCB 166998 | Antirheumatic and anti-inflammatory agent | [ |
|
| Fabaceae | MHJB UFMG | BHCB 161553 | Tonic, analgesic, antiseptic, anti-inflammatory, antipyretic, expectorant, antirheumatic, and laxative | [ |
|
| Fabaceae |
| BHCB 47.468 | ||
|
| Chrysobalanaceae |
| BHCB 152221 | Diabetes | [ |
|
| Asteraceae |
| BHCB 167001 | Asthma, bronchitis | [ |
|
| Eriocaulaceae | Serra do Cipó | BHCB 24241 | Cytotoxic and antimutagenic | [ |
|
| Fabaceae | Ritápolis, MG | BHCB 111231 | Wound healing and for the treatment of inflammation, diarrhea, and leucorrhea | [ |
|
| Fabaceae |
| CGMS 329997 | ||
|
| Combretaceae |
| BHCB 167015 | Antimalarial, anticancer, and anti-inflammatory and for treatment of diarrhea, ulcers, and diabetes | [ |
|
| Vernoniaceae |
| CGMS 11970 | Asthma, hemorrhoids, diabetes, and rheumatism and as diuretic and expectorant and for healing of wounds | [ |
|
| Verbenaceae |
| BHCB 166996 | Emmenagogue, diuretic, and treatment of renal diseases | [ |
Inhibition of TNF-α release by LPS-stimulated THP-1 cells induced by the ethanolic extracts of Brazilian plants.
| Plant species | Plant part | Extraction yield | Concentration | Inhibition of TNF- |
|---|---|---|---|---|
| Control |
|
| ||
|
|
| |||
| Dexamethasone (0.1 | 86.7 ± 1.1 | |||
|
| ||||
|
| Leaves | 39.7 | 250 | −6.9 ± 4.7 |
| 125 | −21.9 ± 13.6 | |||
| 62.5 | −46.0 ± 9.4 | |||
| Stem | 34.2 | 250 | −21.1 ± 6.4 | |
| 125 | −118.2 ± 2.4 | |||
| 62.5 | −83.8 ± 9.7 | |||
|
| ||||
|
| Leaves | 37.8 | 250 | 41.1 ± 3.1 |
| 125 | 4.9 ± 0.3 | |||
| 62.5 | −15.6 ± 0.6 | |||
| Stem | 32.7 | 250 | −78.2 ± 5.1 | |
| 125 | −49.6 ± 8.8 | |||
| 62.5 | −37.2 ± 7.1 | |||
|
| ||||
|
| Leaves | 22.1 | 250 | ND |
| 125 | ND | |||
| 62.5 | ND | |||
| Stem | 18.8 | 250 | ND | |
| 125 | ND | |||
| 62.5 | ND | |||
|
| ||||
|
| Leaves | 13.8 | 250 | 98.6 ± 1.5 |
| 125 | 28.6 ± 9.7 | |||
| 62.5 | 98.6 ± 23.7 | |||
|
| ||||
|
| Leaves | 8.8 | 250 | 98.5 ± 0.6 |
| 125 | 35.5 ± 6.0 | |||
| 62.5 | −11.9 ± 0.9 | |||
|
| ||||
|
| Leaves | 29.4 | 250 | −21.9 ± 4.6 |
| 125 | −60.8 ± 10.1 | |||
| 62.5 | −70.2 ± 7.1 | |||
|
| ||||
|
| Leaves | 16.0 | 250 | 12.3 ± 12.3 |
| 125 | −17.8 ± 2.7 | |||
| 62.5 | −20.4 ± 2.3 | |||
| Stem | 18.7 | 250 | ND | |
| 125 | ND | |||
| 62.5 | ND | |||
|
| ||||
|
| Leaves | 7.7 | 250 | −36.4 ± 15.9 |
| 125 | −18.5 ± 53.2 | |||
| 62.5 | −25.6 ± 24.7 | |||
|
| ||||
|
| Bark | 44.8 | 250 | 42.1 ± 3.1 |
| 125 | 19.3 ± 0.5 | |||
| 62.5 | −9.4 ± 0.8 | |||
|
| ||||
|
| Bark | 33.1 | 250 | 54.2 ± 3.0 |
| 125 | 31.6 ± 1.8 | |||
| 62.5 | 4.4 ± 0.1 | |||
|
| ||||
|
| Leaves | 26.3 | 250 | 42.2 ± 5.3 |
| 125 | 26.5 ± 3.0 | |||
| 62.5 | −0.9 ± 0.1 | |||
| Stem | 29.1 | 250 | −5.3 ± 11.3 | |
| 125 | −8.31 ± 41.5 | |||
| 62.5 | −16.8 ± 28.2 | |||
|
| ||||
|
| Leaves | 31.2 | 250 | 96.2 ± 1.1 |
| 125 | 13.8 ± 0.7 | |||
| 62.5 | −23.6 ± 0.4 | |||
|
| ||||
|
| Leaves | 36.4 | 250 | −35.3 ± 6.3 |
| 125 | −93.2 ± 3.1 | |||
| 62.5 | −66.7 ± 9.0 | |||
| Stem | 32.1 | 250 | −56.7 ± 6.6 | |
| 125 | −48.2 ± 6.9 | |||
| 62.5 | −36.4 ± 2.3 | |||
Concentrations of TNF-α measured in the control (0.1% DMSO) or LPS-stimulated cells.
ND: not determined (cell viability < 90%).
Figure 1Inhibition of TNF-α release by LPS-stimulated THP-1 cells elicited by plant extracts, assayed at 62.5, 125, and 250 µg/mL: (a) Campomanesia lineatifolia (leaves), (b) Stryphnodendron adstringens, (c) Stryphnodendron obovatum, and (d) Terminalia glabrescens (leaves). Data represent the mean inhibition (%) ± standard deviation (SD) from three separate experiments. Means were analyzed by one-way ANOVA, following multiple comparison by Newman-Keuls test (p < 0.05), compared with control (cells + LPS). ∗ indicates significant inhibition of TNF-α release in comparison to LPS-stimulated cells; p < 0.05.
Figure 2Treatments with the aqueous (SAA) and organic (SAO) fractions of Stryphnodendron adstringens reduce total cells and neutrophil recruitment into the knee joint during LPS-induced arthritis. The total number of cells (a) and numbers of neutrophils in the synovial cavity (b) were assessed 12 h after inflammation induction with LPS (vehicle-, V-, SAA-, and SAO-treated mice groups) or PBS (control: C) into the knee joints of mice. The concentration of CXCL1 (c) was assessed by ELISA 12 h after inflammation induction and expressed as pg/100 mg of tissue. Dexamethasone (Dexa, 4 mg/Kg) was used as control. All results are expressed as mean ± standard error of mean (SEM) and are representative of at least two experiments. p < 0.05 when compared to vehicle-treated mice (n = 6) (ANOVA, Student-Newman-Keuls posttest).
Figure 3Chromatograms obtained for the organic fraction (SAO) of Stryphnodendron adstringens, registered by photodiode array detector (PDA) at 220 nm (a) and by electrospray ionization mass spectrometry (ESI-MS) in the negative ion mode of analysis (b). Identified peaks: 1, gallic acid, 2, dimer [two units of (epi)gallocatechin], 3, gallocatechin, 4, dimer [two units of (epi)gallocatechin gallate], 5, dimer [methyl-(epi)gallocatechin gallate and (epi)gallocatechin gallate], 6, epigallocatechin, 7, dimer [(epi)gallocatechin and (epi)gallocatechin gallate], 8, 4′-O-methyl-gallocatechin, 9, dimer [two units of (epi)gallocatechin gallate], 10, epigallocatechin 3-O-gallate, 11, dimer [methyl-(epi)gallocatechin and (epi)gallocatechin], and 12, methyl-(epi)gallocatechin gallate.
Peak assignments and UPLC-ESI-MS fragmentation data obtained for the constituents of the organic fraction of Stryphnodendron adstringens (SAO).
| Number | Postulated compounds | Rt (min) |
| ESI− ions | ESI+ ions | MW | Molecular formula |
|---|---|---|---|---|---|---|---|
| 1 | Gallic acid | 5.96 | 212.3; 269.3 | 169.4 [M − H]−, 125.1 | — | 170 | C7H6O5 |
| 2 | Dimer: two units of (epi)gallocatechin | 8.70 | 271.0 | 609.5 [M − H]−, 137.2, 209.1, 305.3, 423.3, 441.6 | 611.7 [M + H]+, 142.1, 155.2, 187.2 | 610 | C30H26O14 |
| 3 | Gallocatechin | 9.98 | 271.0 | 305.4 [M − H]−, 137.0, 165.2 | 307.5 [M + H]+, 142.1, 164.2, 187.2 | 306 | C15H14O7 |
| 4 | Dimer: two units of (epi)gallocatechin 3- | 12.17 | 271.0 | 913.6 [M − H]−, 137.1, 169.2, 259.2, 382.1, 445.3, 761.5 | 915.6 [M + H]+, 164.2 | 914 | C44H34O22 |
| 5 | Dimer: 4′- | 12.84 | 271.0 | 927.5 [M − H]−, 137.2, 169.3, 305.1, 319.5, 609.2, 762.5 | 164.2, 930.4 | 928 | C45H38O22 |
| 6 | Epigallocatechin | 14.88 | 271.0 | 305.4 [M − H]−, 137.2, 167.1, 179.2 | 307.6 [M + H]+, 139.2, 164.4 | 306 | C15H14O7 |
| 7 | Dimer: (epi)gallocatechin and (epi)gallocatechin 3- | 15.54 | 271.0 | 761.5 [M − H]−, 137.3, 169.0, 305.1, 591.4, 609.9 | 763.5 [M + H]+, 164.1, 208.4 | 762 | C37H30O18 |
| 8 | 4′- | 16.50 | 271.0 | 319.3 [M − H]−, 137.0, 181.2, 220.2, 261.2, 305.3 | 321.3 [M + H]+, 164.4 | 320 | C16H16O7 |
| 9 | Dimer: two units of (epi)gallocatechin 3- | 20.57 | 271.0 | 913.4 [M − H]−, 137.0, 169.2, 319.6, 458.2, 608.7, 775.5 | 915.8 [M + H]+, 164.3, 187.3, 317.1 | 914 | C44H34O22 |
| 10 | Epigallocatechin 3- | 21.97 | 271.0 | 457.3 [M − H]−, 137.2, 169.3, 305.3, 319.1, 331.4 | 459.5 [M + H]+, 164.4, 289.4 | 458 | C22H18O11 |
| 11 | Dimer: 4′- | 23.25 | 271.0 | 623.3 [M − H]−, 137.0, 305.2, 319.6, 440.8 | 624.6 [M + H]+, 164.4 | 624 | C31H30O14 |
| 12 | 4′- | 28.20 | 271.0 | 471.7 [M − H]−, 137.1, 169.1, 319.3 | 473.4 [M + H]+, 164.3, 187.3, 208.5 | 472 | C23H20O11 |
Figure 4Proposal of fragmentation for compounds 5 (a) [dimer of methyl-(epi)gallocatechin gallate and (epi)gallocatechin gallate] and 7 (b) [dimer of (epi)gallocatechin gallate and methyl-(epi)gallocatechin gallate].
Figure 5Characteristic fragments obtained from Retro-Diels-Alder (RDA) fission of a prodelphinidin.